THOMAS APPIO - 27 Feb 2026 Form 4 Insider Report for Bausch Health Companies Inc. (BHC)

Role
Chief Executive Officer, Director
Signature
/s/ Brianna M. Dorsi attorney-in-fact
Issuer symbol
BHC
Transactions as of
27 Feb 2026
Net transactions value
-$7,761,065
Form type
4
Filing time
03 Mar 2026, 17:41:01 UTC
Previous filing
27 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
APPIO THOMAS Chief Executive Officer, Director 400 SOMERSET CORPORATE BOULEVARD, BRIDGEWATER /s/ Brianna M. Dorsi attorney-in-fact 03 Mar 2026 0001683323

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BHC Common Shares, No Par Value Tax liability $492,741 -83,093 -2.3% $5.93 3,536,941 27 Feb 2026 Direct F1
transaction BHC Common Shares, No Par Value Tax liability $498,045 -83,705 -2.4% $5.95 3,453,236 02 Mar 2026 Direct F2
transaction BHC Common Shares, No Par Value Other $6,770,279 -1,137,862 -33% $5.95 2,315,374 02 Mar 2026 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F2 This number represents common shares, no par value, of the Issuer withheld to satisfy the tax withholding obligations due upon vesting of Restricted Share Units.
F3 Reflects the settlement in cash of 1,137,862 performance share unit awards originally granted to the Reporting Person under the Bausch Health Companies, Inc. 2014 Omnibus Incentive Plan on March 2, 2023, which, as previously reported on February 11, 2026, were earned, on February 9, 2026, upon certification by the Talent and Compensation Committee (the "Committee") of the Board of Directors of the Issuer of the level of achievement of the applicable performance metrics, but remained subject to service-based vesting. As disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on March 2, 2026, the Committee subsequently took action to provide for the payment of such earned performance share unit awards in cash rather than Issuer common stock upon vesting. The settlement in cash is exempt under Rule 16b-3(e).